SI2773633T1 - Heterociklične spojine, zdravila, ki vsebujejo te spojine, njihova uporaba in postopki za njihovo pripravo - Google Patents

Heterociklične spojine, zdravila, ki vsebujejo te spojine, njihova uporaba in postopki za njihovo pripravo

Info

Publication number
SI2773633T1
SI2773633T1 SI201231100T SI201231100T SI2773633T1 SI 2773633 T1 SI2773633 T1 SI 2773633T1 SI 201231100 T SI201231100 T SI 201231100T SI 201231100 T SI201231100 T SI 201231100T SI 2773633 T1 SI2773633 T1 SI 2773633T1
Authority
SI
Slovenia
Prior art keywords
compounds
processes
preparation
medicaments containing
heterocyclic compounds
Prior art date
Application number
SI201231100T
Other languages
English (en)
Slovenian (sl)
Inventor
Armin Heckel
Sara Frattini
Dieter Hamprecht
Joerg Kley
Original Assignee
Boehringer Ingelheim International Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim International Gmbh filed Critical Boehringer Ingelheim International Gmbh
Publication of SI2773633T1 publication Critical patent/SI2773633T1/sl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/02Nasal agents, e.g. decongestants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/14Antitussive agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/16Otologicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/10Anthelmintics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Hydrogenated Pyridines (AREA)
SI201231100T 2011-11-02 2012-10-29 Heterociklične spojine, zdravila, ki vsebujejo te spojine, njihova uporaba in postopki za njihovo pripravo SI2773633T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP11187553 2011-11-02
PCT/EP2012/071352 WO2013064450A1 (en) 2011-11-02 2012-10-29 Heterocyclic compounds, medicaments containing said compounds, use thereof and processes for the preparation thereof
EP12777930.4A EP2773633B1 (en) 2011-11-02 2012-10-29 Heterocyclic compounds, medicaments containing said compounds, use thereof and processes for the preparation thereof

Publications (1)

Publication Number Publication Date
SI2773633T1 true SI2773633T1 (sl) 2017-11-30

Family

ID=47073464

Family Applications (1)

Application Number Title Priority Date Filing Date
SI201231100T SI2773633T1 (sl) 2011-11-02 2012-10-29 Heterociklične spojine, zdravila, ki vsebujejo te spojine, njihova uporaba in postopki za njihovo pripravo

Country Status (34)

Country Link
US (4) US8759349B2 (https=)
EP (1) EP2773633B1 (https=)
JP (1) JP6091513B2 (https=)
KR (1) KR102006612B1 (https=)
CN (2) CN104024244B (https=)
AP (1) AP2014007670A0 (https=)
AU (1) AU2012331274B2 (https=)
BR (1) BR112014010583A2 (https=)
CA (1) CA2854217C (https=)
CL (1) CL2014001047A1 (https=)
CO (1) CO6940429A2 (https=)
CY (1) CY1120974T1 (https=)
DK (1) DK2773633T3 (https=)
EA (1) EA025158B9 (https=)
EC (1) ECSP14001929A (https=)
ES (1) ES2645744T3 (https=)
GE (2) GEP20186880B (https=)
HR (1) HRP20171614T1 (https=)
HU (1) HUE034929T2 (https=)
IL (1) IL232035A (https=)
LT (1) LT2773633T (https=)
ME (1) ME02905B (https=)
MX (1) MX348522B (https=)
NO (1) NO2773633T3 (https=)
PE (1) PE20141607A1 (https=)
PH (1) PH12014500970B1 (https=)
PL (1) PL2773633T3 (https=)
PT (1) PT2773633T (https=)
RS (1) RS56498B1 (https=)
SG (1) SG11201401907TA (https=)
SI (1) SI2773633T1 (https=)
TN (1) TN2014000180A1 (https=)
UA (1) UA115868C2 (https=)
WO (1) WO2013064450A1 (https=)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3219705B1 (en) 2005-12-28 2020-03-11 Vertex Pharmaceuticals Incorporated Pharmaceutical compositions of the amorphous form of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
KR102006612B1 (ko) * 2011-11-02 2019-08-02 베링거 인겔하임 인터내셔날 게엠베하 헤테로사이클릭 화합물, 상기 화합물을 포함하는 약제, 이의 용도, 및 이의 제조 방법
AU2014284268A1 (en) * 2013-07-02 2016-01-07 The California Institute For Biomedical Research Compounds for treatment of cystic fibrosis
EP3019492B1 (en) 2013-07-08 2017-09-06 Boehringer Ingelheim International GmbH Amiloride-type compounds as inhibitors in epithelial sodium channels for the treatment of diseases of the lungs and airways
CN107250113B (zh) 2014-10-07 2019-03-29 弗特克斯药品有限公司 囊性纤维化跨膜传导调节蛋白的调节剂的共晶
CA2965467A1 (en) 2014-10-24 2016-04-28 Ono Pharmaceutical Co., Ltd. Kcnq2-5 channel activator
HK1246718A1 (zh) * 2015-01-07 2018-09-14 斯克利普斯研究所 用於治疗囊性纤维化的化合物
GB201610854D0 (en) 2016-06-21 2016-08-03 Entpr Therapeutics Ltd Compounds
GB201619694D0 (en) 2016-11-22 2017-01-04 Entpr Therapeutics Ltd Compounds
GB201717051D0 (en) 2017-10-17 2017-11-29 Enterprise Therapeutics Ltd Compounds
GB201808093D0 (en) 2018-05-18 2018-07-04 Enterprise Therapeutics Ltd Compounds
JP2023541601A (ja) 2020-09-10 2023-10-03 プレシリックス・ナームローゼ・ベンノートシヤープ Fapに対する抗体フラグメント
CN112107580A (zh) * 2020-09-29 2020-12-22 北京鑫开元医药科技有限公司 一种脾酪氨酸激酶抑制剂的制剂组合物及其制备方法
WO2023203135A1 (en) 2022-04-22 2023-10-26 Precirix N.V. Improved radiolabelled antibody
CA3251753A1 (en) 2022-05-02 2023-11-09 Precirix N.V. PRE-TARGETTING
WO2024243025A1 (en) * 2023-05-19 2024-11-28 Ikena Oncology, Inc. Naphthyl-substituted pyrido[4,3-d]pyrimidines and related compounds and their use in treating medical conditions

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL6812003A (https=) 1967-09-07 1969-03-11
US3953476A (en) 1971-12-27 1976-04-27 Merck & Co., Inc. 3-Amino-5-sulfonylbenzoic acids
KR20020038694A (ko) 1999-07-19 2002-05-23 프란시스 제이 메이어 소듐 채널 차단제의 콘쥬게이트 및 그 이용방법
JP2003520042A (ja) 2000-01-24 2003-07-02 アイシス・ファーマシューティカルス・インコーポレーテッド 誘導性一酸化窒素シンターゼ発現のアンチセンスモジュレーション
US7956059B2 (en) 2004-08-18 2011-06-07 Parion Sciences, Inc. Aliphatic amide and ester pyrazinoylguanidine sodium channel blockers
GB0526244D0 (en) 2005-12-22 2006-02-01 Novartis Ag Organic compounds
US20080124276A1 (en) * 2006-07-24 2008-05-29 Lifeline Cell Technology Synthetic cornea from retinal stem cells
DE602008005140D1 (de) * 2007-05-07 2011-04-07 Novartis Ag Organische verbindungen
MX2010006421A (es) 2007-12-10 2010-06-25 Novartis Ag Compuestos organicos.
CA2723938A1 (en) * 2008-05-13 2009-11-19 Novartis Ag 3,5-diamino-6-chloro-pyrazine-2-carboxylic acid derivatives and their use as epithelial sodium channel blockers for the treatment of airway diseases
JP2011522860A (ja) 2008-06-10 2011-08-04 ノバルティス アーゲー 上皮性ナトリウムチャネルブロッカーとしてのピラジン誘導体
US9050339B2 (en) 2010-09-17 2015-06-09 Novartis Ag Pyrazine derivatives as ENaC blockers
US8372845B2 (en) 2010-09-17 2013-02-12 Novartis Ag Pyrazine derivatives as enac blockers
AR086745A1 (es) 2011-06-27 2014-01-22 Parion Sciences Inc 3,5-diamino-6-cloro-n-(n-(4-(4-(2-(hexil(2,3,4,5,6-pentahidroxihexil)amino)etoxi)fenil)butil)carbamimidoil)pirazina-2-carboxamida
CN103687488B (zh) 2011-06-27 2015-06-10 帕里昂科学公司 化学和代谢稳定的具有钠通道阻滞剂活性的二肽
KR102006612B1 (ko) * 2011-11-02 2019-08-02 베링거 인겔하임 인터내셔날 게엠베하 헤테로사이클릭 화합물, 상기 화합물을 포함하는 약제, 이의 용도, 및 이의 제조 방법
CA2854221A1 (en) 2011-11-02 2013-05-10 Boehringer Ingelheim International Gmbh Novel process for the preparation of acylguanidines and acylthioureas

Also Published As

Publication number Publication date
JP2014534222A (ja) 2014-12-18
HK1196819A1 (zh) 2014-12-24
CA2854217C (en) 2019-12-31
EP2773633A1 (en) 2014-09-10
US8759349B2 (en) 2014-06-24
IL232035A0 (en) 2014-05-28
NO2773633T3 (https=) 2017-12-30
CN104024244A (zh) 2014-09-03
US9920035B2 (en) 2018-03-20
ECSP14001929A (es) 2015-11-30
PT2773633T (pt) 2017-11-14
US20130109697A1 (en) 2013-05-02
IL232035A (en) 2017-05-29
CN106279110B (zh) 2019-12-10
AU2012331274A1 (en) 2014-04-03
CA2854217A1 (en) 2013-05-10
US20180194747A1 (en) 2018-07-12
US20140228374A1 (en) 2014-08-14
CL2014001047A1 (es) 2014-11-07
TN2014000180A1 (en) 2015-09-30
DK2773633T3 (da) 2017-11-13
MX2014005166A (es) 2014-05-28
AP2014007670A0 (en) 2014-05-31
BR112014010583A2 (pt) 2020-04-22
HRP20171614T1 (hr) 2017-12-01
JP6091513B2 (ja) 2017-03-08
EA025158B1 (ru) 2016-11-30
WO2013064450A1 (en) 2013-05-10
NZ622469A (en) 2016-08-26
PL2773633T3 (pl) 2018-01-31
AU2012331274B2 (en) 2017-06-08
GEAP201813485A (en) 2018-04-10
HUE034929T2 (en) 2018-03-28
ES2645744T3 (es) 2017-12-07
PH12014500970B1 (en) 2017-10-06
GEP20186880B (en) 2018-07-25
EA201400521A1 (ru) 2014-09-30
EP2773633B1 (en) 2017-08-02
UA115868C2 (uk) 2018-01-10
CO6940429A2 (es) 2014-05-09
CN106279110A (zh) 2017-01-04
SG11201401907TA (en) 2014-05-29
KR102006612B1 (ko) 2019-08-02
PE20141607A1 (es) 2014-11-23
CY1120974T1 (el) 2019-12-11
EA025158B9 (ru) 2018-03-30
LT2773633T (lt) 2017-11-10
RS56498B1 (sr) 2018-01-31
MX348522B (es) 2017-06-16
US20150336933A1 (en) 2015-11-26
KR20140085498A (ko) 2014-07-07
CN104024244B (zh) 2016-09-14
PH12014500970A1 (en) 2014-06-09
ME02905B (me) 2018-10-20

Similar Documents

Publication Publication Date Title
PH12014500970A1 (en) Heterocyclic compounds, medicaments containing said compounds, use thereof and processes for the preparation thereof
IL269858A (en) Pyridone and aza-pyridone compounds, pharmaceutical composition and kits comprising the same and uses thereof
IL233154A (en) Compounds, pharmaceuticals containing them and their uses
IL231382A (en) History of benzonitrile, their preparation and medications containing them
ZA201208198B (en) Picolinamide and pyrimidine-4-carboxamine compounds, process for preparing and pharmaceutical composition comprising the same
PT2793578T (pt) Derivados de sulfureto de trifluoroetilo n-arilamidinasubstituídos como acaricidas e inseticidas
AP2014007399A0 (en) Phenyl-3-AZA-bicycloÄ3.1.0Ühex-3-YL-methanones andthe use thereof as medicament
EP2699091A4 (en) 2 ', 6'-dioxo-3'-deutero-PIPERIDIN-3-YL-isoindoline COMPOUNDS
PL2678332T3 (pl) Pochodne diaminopirymidyny i sposoby ich wytwarzania
ZA201407021B (en) Novel thienopyrimidine derivatives,processes for the preparation thereof and therapeutic uses thereof
EP2924042A4 (en) BIS-BETA-CARBOLINE COMPOUND AND METHOD OF MANUFACTURING, PHARMACEUTICAL COMPOSITION AND USE THEREOF
IL239146A0 (en) Aminocyclobutane derivatives, methods for their preparation and their use as drugs
IL232061A (en) The heterocyclic compound in the bicycle, a pharmaceutical product containing it and its use
ZA201501985B (en) Combination drug comprising gemigliptin and metformin,and method for the preparation thereof
PL2854765T3 (pl) Farmaceutyczny roztwór pemetreksedu
IL237688A0 (en) A syringe containing a preparation, in particular a pharmaceutical preparation containing immunoglobulins, a method for its production and use
IL252033B (en) History of spiro and processes for their preparation
EP2930175A4 (en) NOVEL OCTAHYDROPYRIDOQUINAZOLINE DERIVATIVE, PHARMACEUTICAL COMPOSITION CONTAINING THE SAME, AND USES THEREFOR, AND THE DERIVATIVE THEREOF
IL237432B (en) Amine salt, its crystals and pharmaceutical preparations containing it
PL391810A1 (pl) Nowe sole ziprasidonu oraz sposoby ich otrzymywania
PL395175A1 (pl) Nowe pochodne dekstrometorfanu i sposób ich wytwarzania
PL398987A1 (pl) (Z)-6-siarczan-6,4'-dihydroksy-7-prenylo-4-metoksyauronu i sposób jego wytwarzania
IL234008A0 (en) A process for obtaining a pharmaceutical preparation based on modafinil, the obtained pharmaceutical preparation and its use
AU2012900131A0 (en) "Heterocyclic compounds"
PL394762A1 (pl) Fotochromowe pochodne 4-amino-N-(6-metoksypirydazyn-3-ilo)benzenosulfonamidu i sposób ich otrzymywania